A detailed history of Franklin Resources Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 4,012,048 shares of EYPT stock, worth $33.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,012,048
Previous 4,012,048 -0.0%
Holding current value
$33.1 Million
Previous $32.1 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.58 - $10.54 $2.75 Million - $3.82 Million
362,399 Added 9.93%
4,012,048 $32.1 Million
Q2 2024

Aug 14, 2024

BUY
$8.16 - $22.89 $2.12 Million - $5.96 Million
260,412 Added 7.68%
3,649,649 $31.8 Million
Q1 2024

May 13, 2024

SELL
$19.93 - $29.71 $24.9 Million - $37.2 Million
-1,251,414 Reduced 26.97%
3,389,237 $70.1 Million
Q4 2023

Feb 09, 2024

BUY
$5.71 - $24.13 $2.79 Million - $11.8 Million
488,206 Added 11.76%
4,640,651 $107 Million
Q3 2023

Nov 13, 2023

SELL
$7.99 - $15.36 $7.29 Million - $14 Million
-912,138 Reduced 18.01%
4,152,445 $33.2 Million
Q2 2023

Aug 11, 2023

SELL
$3.03 - $9.0 $2.16 Million - $6.42 Million
-713,557 Reduced 12.35%
5,064,583 $44.1 Million
Q1 2023

May 12, 2023

BUY
$2.28 - $5.04 $8,278 - $18,300
3,631 Added 0.06%
5,778,140 $17 Million
Q4 2022

Feb 10, 2023

BUY
$2.37 - $7.2 $390,177 - $1.19 Million
164,632 Added 2.93%
5,774,509 $20.2 Million
Q3 2022

Nov 14, 2022

BUY
$6.96 - $11.12 $1.11 Million - $1.78 Million
159,624 Added 2.93%
5,609,877 $44.4 Million
Q2 2022

Aug 11, 2022

BUY
$7.25 - $12.71 $945,581 - $1.66 Million
130,425 Added 2.45%
5,450,253 $42.9 Million
Q1 2022

May 13, 2022

BUY
$8.67 - $14.11 $3.23 Million - $5.26 Million
372,663 Added 7.53%
5,319,828 $64.6 Million
Q4 2021

Feb 11, 2022

BUY
$10.18 - $18.4 $18 Million - $32.6 Million
1,772,828 Added 55.85%
4,947,165 $60.6 Million
Q3 2021

Nov 12, 2021

BUY
$7.51 - $11.72 $2.84 Million - $4.43 Million
377,664 Added 13.5%
3,174,337 $33.1 Million
Q2 2021

Aug 13, 2021

SELL
$8.69 - $11.08 $795,778 - $1.01 Million
-91,574 Reduced 3.17%
2,796,673 $25.1 Million
Q1 2021

May 13, 2021

BUY
$8.89 - $14.92 $13.1 Million - $22 Million
1,474,300 Added 104.27%
2,888,247 $29.3 Million
Q4 2020

Feb 10, 2021

BUY
$3.7 - $6.58 $5.23 Million - $9.3 Million
1,413,947 New
1,413,947 $9.3 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $281M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.